Geneva: The World Health Organization has said that it has excluded Gilead Sciences’ antiviral drug Remedisvir from its’ Prequalification List ‘. Explain that this list of the World Health Organization is an official list of medicines used by developing countries as a benchmark for procurement.
WHO spokesman Tariq Jasarevic said that, we have suspended Remedisvir from the Prequalification List. This suspension is an indication for countries that WHO does not recommend countries to purchase Remedisvir for the treatment of corona according to treatment guidelines.
Earlier on Friday, the World Health Organization warned that the antiviral drug Remedisvir should not be used to treat Covid patients, no matter how ill they may be, because there is no evidence that it works in fighting the virus. is. The demand for Remedisvir in India had increased rapidly after the rise in Corona cases in the past.
